Trial intelligence / Profile preview

Urea, arginine and carnosine cream versus glycerin cream for severe foot xerosis in type 2 diabetes

ISRCTN13923163Phase 4Completed

Sponsor
ISDIN
Start
Nov 2013
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 4, single-blind trial of urea + arginine + carnosine and glycerol in Asteatosis (2 arms), sponsored by ISDIN. Primary endpoints: Change in Xerosis Assessment Scale score at week 32 and Change in Overall Cutaneous Score at week 32. Started Nov 2013; status: completed.

02

Drugs

urea + arginine + carnosineglycerol
03

Conditions

Asteatosis

Beyond the preview

Go deeper on ISRCTN13923163.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN13923163.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call